6-Year Follow-Up Confirms Durable Efficacy of BRL-101 in β‑Thalassemia

World's First! BRL Medicin's BCMA UCAR-T Successfully Treats Neuromyelitis Optica Spectrum Disorder

The First Patient Treated with BRL Medicine’s BRL-201 Therapy Achieves Over 5 Years of Cancer-Free Survival

World's first β0/β0 severe thalassemia patient cured for 5 years by BRL-101

World's First! BRL Medicine's UCAR-T Successfully Treat Relapsed/Refractory Systemic Lupus Erythematosus

BRL Medicine Team Publishes Groundbreaking Review in Cancer Cell: CAR-T Therapy for Solid Tumors